GBS Venture Partners - GBS Venture Partners Home Company Team Investment Approach For Entrepreneurs Portfolio Companies News Events Contact Us div"> Otsuka Pharmaceutical Submits New Drug Application to U.S. FDA for Centanafadine for the Treatment of ADHD in Children, Adolescents, and Adults 25 / 11 / 2025 > Read More Otsuka Pharmaceutical Announces Positive Topline Results from Two Pivotal Phase 3 Trials of Centanafadine as a Treatment for Adolescents and Children with Attention-Deficit/Hyperactivity Disorder (ADHD) 27 / 10 / 2023 > Read More FDA Authorizes Marketing of MISHA™ Knee System for People Suffering from Knee Osteoarthritis 10 / 04 / 2023 > Read More
🔒 Sign up for free to view key contact information
Sign up free →This profile has not yet been verified by the firm. Information may be incomplete or outdated. Claim this profile to take control of your listing.
Location
Melbourne, Australia
Claim this profile to complete your information, set investment criteria, and start receiving curated deal flow from sponsors on DEALITHIC.